Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,095 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04540705 | A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread(PIVOT IO 011) | completed | Phase 1 | 30 | Bristol-Myers SquibbINDUSTRY | 8 | Feb 28, 2024 | clinicaltrials |
| NCT06206083 | Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis | recruiting | — | 64 | National Institute of Cancerología |
| 1 |
| Feb 28, 2024 |
| clinicaltrials |
| NCT04227457 | Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America(LATINO Lung) | completed | — | 700 | Latin American Cooperative Oncology GroupOTHER | 5 | Feb 20, 2024 | clinicaltrials |
| NCT04964908 | Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia(CREEK) | completed | — | 1,088 | AstraZenecaINDUSTRY | 17 | Feb 20, 2024 | clinicaltrials |
| NCT01542437 | Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 66 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05999097 | To Study the Effect of SC-FOS Prebiotics in Women With Polycystic Ovary Syndrome | unknown | N/A | 40 | Universidad Autonoma de ChihuahuaOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT01894633 | Study of Whole-brain Irradiation With Chloroquine for Brain Metastases(CLQ) | terminated | Phase 2 | 73 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT03674112 | A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer(PHranceSCa) | completed | Phase 2 | 160 | Hoffmann-La RocheINDUSTRY | 17 | Jan 2, 2024 | clinicaltrials |
| NCT03669718 | A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC | unknown | Phase 2 | 194 | ISA PharmaceuticalsINDUSTRY | 13 | Dec 29, 2023 | clinicaltrials |
| NCT04151563 | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy(CheckMate 79X) | withdrawn | Phase 1 / Phase 2 | 0 | Bristol-Myers SquibbINDUSTRY | 10 | Dec 19, 2023 | clinicaltrials |
| NCT03980314 | A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection | completed | Phase 1 | 261 | Bristol-Myers SquibbINDUSTRY | 14 | Dec 15, 2023 | clinicaltrials |
| NCT05444972 | A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review(METER) | completed | — | 998 | AbbVieINDUSTRY | 14 | Dec 11, 2023 | clinicaltrials |
| NCT02422615 | Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-3) | completed | Phase 3 | 726 | Novartis PharmaceuticalsINDUSTRY | 30 | Nov 30, 2023 | clinicaltrials |
| NCT04596865 | Recurrence After Whipple's (RAW) Study | completed | — | 1,484 | University Hospital Plymouth NHS TrustOTHER | 8 | Nov 18, 2023 | clinicaltrials |
| NCT03750539 | Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer | unknown | N/A | 100 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT03899376 | A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT(ATGCRT) | unknown | N/A | 80 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT04067882 | Validation of the Genetic Signature 354849 as a Prognostic Method | unknown | — | 189 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT04070976 | Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer | unknown | N/A | 82 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02488759 | An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors(CheckMate358) | completed | Phase 1 / Phase 2 | 578 | Bristol-Myers SquibbINDUSTRY | 11 | Nov 13, 2023 | clinicaltrials |
| NCT06124469 | UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | completed | — | 99 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 9, 2023 | clinicaltrials |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT06090747 | Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. | recruiting | N/A | 146 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03120949 | Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis(CREDO 4) | completed | Phase 3 | 2,106 | R-Pharm International, LLCINDUSTRY | 18 | Oct 12, 2023 | clinicaltrials |
| NCT02125461 | A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer(PACIFIC) | completed | Phase 3 | 713 | AstraZenecaINDUSTRY | 26 | Oct 10, 2023 | clinicaltrials |
| NCT04040881 | Accuracy of a Mobile Sensor-Based System for the Detection of Chemotherapy Toxicity in Older Adults With Cancer in a Developing Country | completed | N/A | 116 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT02305173 | Dexamethasone and Respiratory Function After Mastectomy(Dexa-mama) | completed | Phase 3 | 120 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Oct 3, 2023 | clinicaltrials |
| NCT04471818 | Ketamine or Placebo in Patients With Major Depression and Advanced Cancer(KODIAC) | completed | Phase 1 / Phase 2 | 19 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03302234 | Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) | completed | Phase 3 | 568 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Sep 26, 2023 | clinicaltrials |
| NCT02312258 | A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) | completed | Phase 3 | 706 | TakedaINDUSTRY | 35 | Sep 21, 2023 | clinicaltrials |
| NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(CheckMate 651) | completed | Phase 3 | 947 | Bristol-Myers SquibbINDUSTRY | 18 | Sep 21, 2023 | clinicaltrials |
| NCT02760433 | Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease(CREDO 3) | completed | Phase 3 | 368 | R-Pharm International, LLCINDUSTRY | 11 | Sep 21, 2023 | clinicaltrials |
| NCT06031753 | Effects of Intermittent Fasting on Polycystic Ovary Syndrome (PCOS) Compared to Standard Treatment | completed | N/A | 16 | Instituto Superior de Investigación en Estética Médica, Nutrición y Anti-EnvejecimientoOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT02499120 | Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer | completed | Phase 2 | 125 | PfizerINDUSTRY | 15 | Sep 8, 2023 | clinicaltrials |
| NCT04089488 | Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America | completed | — | 175 | AIDS Malignancy ConsortiumNETWORK | 3 | Sep 1, 2023 | clinicaltrials |
| NCT02426125 | A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer(RANGE) | completed | Phase 3 | 530 | Eli Lilly and CompanyINDUSTRY | 23 | Aug 21, 2023 | clinicaltrials |
| NCT04742192 | Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer(EARLY-EGFR) | completed | — | 601 | AstraZenecaINDUSTRY | 15 | Aug 14, 2023 | clinicaltrials |
| NCT02763579 | A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)(IMpower133) | completed | Phase 3 | 503 | Hoffmann-La RocheINDUSTRY | 21 | Jul 28, 2023 | clinicaltrials |
| NCT03185013 | REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)(REVEAL 1) | completed | Phase 3 | 201 | Inovio PharmaceuticalsINDUSTRY | 19 | Jul 27, 2023 | clinicaltrials |
| NCT05950204 | Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia. | unknown | N/A | 40 | Coordinación de Investigación en Salud, MexicoOTHER_GOV | 1 | Jul 18, 2023 | clinicaltrials |
| NCT03779191 | Alectinib in Combination With Bevacizumab in ALK Positive NSCLC | completed | Phase 2 | 41 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05830461 | Online Psychological Care Program for Women Who Attend a Breast Clinic. | unknown | N/A | 50 | University of GuadalajaraOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT02869789 | An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | completed | Phase 4 | 1,041 | Bristol-Myers SquibbINDUSTRY | 21 | Jun 15, 2023 | clinicaltrials |
| NCT05581784 | Effectiveness of a Pain Neuroscience Education Program in Adults With Cancer Pain | unknown | N/A | 80 | Instituto Neurociencia Del DolorOTHER | 3 | Jun 15, 2023 | clinicaltrials |
| NCT02303444 | An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors(RIFTOS MKI) | completed | — | 667 | BayerINDUSTRY | 19 | Jun 8, 2023 | clinicaltrials |
| NCT03519256 | A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder(CheckMate 9UT) | terminated | Phase 2 | 142 | Bristol-Myers SquibbINDUSTRY | 15 | Jun 1, 2023 | clinicaltrials |
| NCT00946712 | S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer | terminated | Phase 3 | 1,333 | SWOG Cancer Research NetworkNETWORK | 2 | May 23, 2023 | clinicaltrials |
| NCT02573324 | A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification(Intellance1) | completed | Phase 3 | 691 | AbbVieINDUSTRY | 28 | May 11, 2023 | clinicaltrials |
| NCT02805530 | Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma | completed | N/A | 36 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | May 6, 2023 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials